
    
      To test oncological feasibility, compliance of nodal dissection was selected as a primary end
      point. When there are more than two missing nodal station(no lymph nodes in dissected area),
      it is defined as a non-compliant nodal dissection. Other secondary outcomes will be
      supplementary to evaluate feasibility of D2 dissection.
    
  